What You Should Know:
- PathAI, a leader in AI-powered digital pathology solutions, announced today the launch of AIM-MASH on its AISight Image Management System (IMS).
- The new product offers advanced AI-based measurement tools to support pathologists in assessing Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) using the MASH Clinical Research Network (CRN) Activity Score.
AIM-MASH Integration with AISight
By integrating AIM-MASH with AISight, PathAI
Read More
Digital Health | News, Analysis, Insights - HIT Consultant
Citeline Launches AI-Powered Tools for Clinical Trials
What You Should Know:
- Citeline, a provider of intelligence solutions for the life sciences industry, today announced the launch of Protocol SmartDesign and Investigator SmartSelect, two new AI-powered tools designed to streamline and optimize clinical trial development.
- These innovative solutions are part of the Citeline SmartSolutions suite, which leverages the company's extensive data assets to deliver actionable insights for life sciences organizations.
How Protocol
Read More
AI-Driven Medication Advisor Launched by MedAdvisor and BEN
What You Should Know:
- MedAdvisor Solutions and Brand Engagement Network (BEN) today announced the launch of their AI-driven medication advisor.
- This innovative solution is designed to enhance patient engagement, reduce pharmacist workload, and improve medication adherence.
AI-driven Medication Advisor
The medication advisor will be showcased at the upcoming National Association of Chain Drug Stores (NACDS) Total Store Expo, where attendees can interact with a
Read More
Absci and MSK Collaborate on Generative AI Drug Discovery
What You Should Know:
- Absci Corporation, a leader in generative AI drug creation, today announced a strategic collaboration with Memorial Sloan Kettering Cancer Center (MSK) to develop up to six novel cancer therapeutics.
- By combining Absci’s AI platform with MSK’s renowned cancer research expertise, the partnership aims to accelerate the discovery and development of new treatments for this devastating disease.
Absci's Integrated Drug Creation Platform
Absci's Integrated
Read More
Create Health Ventures Launches $21M Fund to Invest in Digital Health Startups
What You Should Know:
- Create Health Ventures, a venture capital firm dedicated to early-stage digital health startups, announced the closing of its $21M inaugural fund.
- The VC firm will invest in B2B solutions that address critical challenges within the healthcare industry, including improving patient engagement, enhancing care delivery, and optimizing clinical trials.
Founding Team
Founded by healthcare industry veterans Cartmell and Amit Aysola, Create Health Ventures brings
Read More
Sheba Medical Center Develops AI Algorithm to Predict Pulmonary Embolism
What You Should Know:
- Sheba Medical Center, a globally recognized healthcare leader, announced the publication of a groundbreaking study demonstrating the effectiveness of an AI algorithm in predicting pulmonary embolism (PE) risk upon hospital admission.
- The research, published in the Journal of Medical Internet Research, involved analyzing medical records of over 46,000 patients and identifying a machine learning model capable of accurately predicting PE
Read More
Patients Demand Improved Healthcare Support, Hyro Survey Finds
What You Should Know:
- A new survey conducted by Hyro, a healthcare AI-powered communications company, has revealed significant gaps in patient support within the US healthcare system.
- The survey of over 1,500 patients highlights the frustration and challenges patients face when interacting with healthcare providers.
Patients Reveals Alarming Consequences of Healthcare Support Friction
Hyro's "Voice of the Patient" report emphasizes the urgent need for healthcare
Read More
Luminopia’s Amblyopia Treatment Gains Coverage from Highmark
What You Should Know:
- Luminopia, a digital health company focused on treating neuro-visual disorders, announced today that Highmark has approved coverage for its FDA-cleared therapy for children with amblyopia.
- This decision marks a significant milestone for Luminopia, as it expands access to its innovative treatment for a condition that affects millions of children.
What is Amblyopia?
Amblyopia, commonly known as lazy eye, is a leading cause of vision loss in
Read More
FuturHealth Combines GLP-1 Medications with Personalized Nutrition
What You Should Know:
- FuturHealth, a leader in personalized weight-loss solutions launches its Custom Meal Plans. Designed to complement the growing popularity of GLP-1 medications, the new offering provides a comprehensive approach to weight management and long-term health.
- As the use of GLP-1 medications surges, FuturHealth recognizes the need for a holistic approach to weight loss. By combining personalized meal plans with medication, FuturHealth aims to help individuals
Read More
Report: Urgent Need for Employer-Supported Substance Use Programs
What You Should Know:
- Pelago, a digital clinic partner for substance use management, released its 2024 Annual State of Substance Use Management Trend Report.
- The report underscores the critical role employers play in addressing the widespread issue of substance use in the American workforce.
Employers Urged to Support Substance Use Management
The survey of 1,210 U.S. workers revealed a significant gap in employer support for substance use management. While over half
Read More
